<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is aetiologically associated with <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-esophageal reflux</z:e>, but the mechanisms responsible for the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath> sequence are unknown </plain></SENT>
<SENT sid="1" pm="."><plain>Bile components are implicated </plain></SENT>
<SENT sid="2" pm="."><plain>Impaired gallbladder function may contribute to <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenogastric reflux</z:e> (DGR) and harmful <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>AIMS: This study aims to compare gallbladder function in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, and controls </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Three groups of patients, <z:hpo ids='HP_0000001'>all</z:hpo> free of <z:mp ids='MP_0002830'>gallstone</z:mp> disease, were studied </plain></SENT>
<SENT sid="5" pm="."><plain>Group 1: (n = 15) were <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="6" pm="."><plain>Group 2: (n = 15) were patients with &gt;3-cm-long segment of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Group 3: (n = 15) were patients with esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Using real-time ultrasonography unit, gallbladder volume was measured in subjects following a 10-h fast </plain></SENT>
<SENT sid="9" pm="."><plain>Ejection fraction was calculated before and after standard liquid meal and compared between the groups </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: The mean percentage reduction in gallbladder volume was 50% at 40 min in the <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> group compared with 72.4% in the control group (p &lt; 0.001) </plain></SENT>
<SENT sid="11" pm="."><plain>At 60 min, gallbladder filling had recommenced in the control group to 64.1% of fasting volume while continuing to empty with further reduction to 63% in the Barrett's group and to 50.6% (p = 0.008) in the <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> group </plain></SENT>
<SENT sid="12" pm="."><plain>The mean gallbladder ejection fraction decreased progressively from controls to Barrett's to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and was significantly lower in Barrett's group (60.9%; p = 0.019) and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> group (47.9%; p &lt; 0.001) compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls (70.9%) </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: Gallbladder function is progressively impaired in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="14" pm="."><plain>Gallbladder malfunction increases <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenogastric reflux</z:e>, exposing the lower esophagus to an altered chemical milieu which, in turn, may have a role in promoting <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:hpo ids='HP_0002664'>neoplasia</z:hpo> sequence in the lower esophageal mucosa </plain></SENT>
</text></document>